Related Experiment Video
Updated: Dec 19, 2025

09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
26.3K
D1 Dopamine Receptor Activation Induces Neuronal eEF2 Pathway-Dependent Protein Synthesis
Orit David1, Iliana Barrera1,2, Nathaniel Gould1
1Sagol Department of Neurobiology, University of Haifa, Haifa, Israel.
Frontiers in Molecular Neuroscience
|June 6, 2020
Summary
Dopamine D1 receptor activation dephosphorylates eEF2, enhancing protein synthesis and offering a new therapeutic target for psychiatric disorders like addiction and depression.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Dopamine modulates brain states via mRNA translation, but its specific signaling pathways in psychiatric disorders remain unclear.
- Understanding dopamine's effects on neuronal mRNA translation is crucial for developing treatments for mental health conditions.
Purpose of the Study:
- To elucidate the molecular pathways downstream of dopamine receptors involved in mRNA translation.
- To investigate the role of dopamine receptor D1 in regulating neuronal translation and its potential as a therapeutic target.
Main Methods:
- Utilized genetic, pharmacologic, biochemical, and imaging techniques in primary cortical neuronal cultures.
- Examined the phosphorylation status of eukaryotic elongation factor 2 (eEF2) and eukaryotic initiation factor 2 alpha (eIF2α).
- Investigated the involvement of NMDA receptor, mTOR, and ERK pathways in dopamine D1 receptor signaling.
Main Results:
- Dopamine D1 receptor activation, but not D2, caused rapid dephosphorylation of eEF2 at Thr56.
- NMDA receptor, mTOR, and ERK pathways were identified as upstream activators of D1-dependent eEF2 dephosphorylation.
- D1 activation reduced dendritic eEF2 phosphorylation, increased BDNF and synapsin2b expression, and boosted protein synthesis.
Conclusions:
- Dopamine D1 receptor signaling regulates eEF2-mediated translation in neurons.
- eEF2 represents a potential therapeutic target for addiction, depression, and other psychiatric disorders.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
2.0K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K
The Unfolded Protein Response
6.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.1K
MAPK Signaling Cascades
7.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.6K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Directing Proteins to the Rough Endoplasmic Reticulum
16.3K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
16.3K
IP3/DAG Signaling Pathway
13.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
13.9K

